A multi-asset biopharmaceutical company focused on the acquisition, development, and commercialization of innovative therapeutics that aim to improve outcomes for patients with rare and specialty diseases.
Lead Underwriter
BMO Capital Markets Corp ,Cowen and Company, LLC ,RBC Capital Markets, LLC
